Skip to content
ClinCalc Pro
Menu
Alpha-1 Adrenergic Agonist (Pure Vasoconstrictor)

Phenylephrine

Brand names: Metaraminol (different drug, sometimes confused)

Phenylephrine is a selective alpha-1 adrenergic agonist vasopressor used to treat hypotension, particularly during anaesthesia and spinal/epidural-induced hypotension.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It stimulates alpha-1 adrenoceptors on vascular smooth muscle to produce peripheral vasoconstriction, raising systemic vascular resistance and blood pressure.

Prescribing in practice

  • The rise in blood pressure can trigger a reflex bradycardia, so heart rate must be watched and the drug used with caution where bradycardia or fixed cardiac output is a concern.
  • It is preferred where vasoconstriction without inotropy is desired, but extravasation of concentrated solutions can cause local ischaemia and tissue necrosis.
  • Use with caution in patients with hypertension, severe coronary disease or peripheral vascular disease, and account for exaggerated responses with monoamine oxidase inhibitors.

Monitoring

Continuous blood pressure and heart rate monitoring is required, ideally with the infusion titrated to a defined haemodynamic target.

Counselling the patient

  • This is given by trained staff with close blood pressure monitoring.
  • Report any pain or skin changes at the infusion site promptly.

Evidence & guidelines

Its use as a vasopressor, including for maternal hypotension during spinal anaesthesia for caesarean section, is well established in anaesthetic practice.

Reference: Ngan Kee (Anesthesiology 2009); OAA/AAGBI Obstetric Anaesthesia Guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.